Regulatory Affairs & Quality Assurance

Description :

Regulatory Affairs for clinical trials is the major part in the clinical trials approaches. Every clinical trial must be analyzed according to the Regulatory Affairs Guidelines. number of  Regulatory Affairs departments will be there depending upon the countries within the ever-growing pace of companies. Global Harmonization in standards has led to a consistent approach in regulatory submissions 
Quality Assurance plays a major role in the pharma industry for development of products and services in pharma and biotech, as part of GMPs (Good Manufacturing Practices). Quality Assurance refers to the step-by-step procedure of examining the drugs in pharma industry to meet specific quality, efficacy, and safety as per their intended use.

Related: Regulatory Affairs Conferences | Regulatory Affairs Conferences 2020 | Regulatory Affairs Congress |  Regulatory Affairs Congress 2020 | Regulatory Affairs Meetings | Regulatory Affairs Meetings 2020 | Regulatory Affairs Events | Regulatory Affairs Events 2020 |Quality Assurance Conferences | Quality Assurance Conferences 2020 | Quality Assurance Congress | Quality Assurance Congress 2020 | Quality Assurance Meetings | Quality Assurance Meetings 2020 | Quality Assurance Events | Quality Assurance Events 2020

Pharmacology & Drug Development Congress; Digi-Tech Pharma & AI 2020, Digi-Tech Pharma & AI 2020; European Congress on Pharma; Formulations 2020; Global Conference on Pharmaceutics and Pharmacology; Global Pharmacy Conference.

Related Associations: National Pharmaceutical Association; Parenteral Drug Association ; Phi Delta Chi Professional Pharmacy Fraternity; Phi Lambda Sigma Society; Pediatric Pharmacy Advocacy Group; Rho Chi Society; Student National Pharmacy Association; Society of Toxicology; National Alliance of State Pharmacy Associations; American Association of Pharmacy Technicians